"Interleukins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli.
| Descriptor ID |
D007378
|
| MeSH Number(s) |
D12.644.276.374.465 D12.776.467.374.465 D23.529.374.465
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Interleukins".
Below are MeSH descriptors whose meaning is more specific than "Interleukins".
This graph shows the total number of publications written about "Interleukins" by people in this website by year, and whether "Interleukins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 3 | 1 | 4 |
| 2011 | 3 | 0 | 3 |
| 2012 | 6 | 0 | 6 |
| 2013 | 3 | 2 | 5 |
| 2014 | 1 | 3 | 4 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 40 | 35 | 75 |
| 2018 | 33 | 21 | 54 |
| 2019 | 13 | 8 | 21 |
| 2020 | 4 | 7 | 11 |
| 2021 | 7 | 6 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Interleukins" by people in Profiles.
-
Interleukin-21: a potential biomarker for diagnosis and predicting prognosis in COVID-19 patients Turk J Med Sci. 2021 10 21; 51(5):2274-2284.
-
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19. J Med Virol. 2022 01; 94(1):154-160.
-
IFN-?1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses. Viruses. 2021 08 12; 13(8).
-
Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19. J Med Microbiol. 2021 Jul; 70(7).
-
An Impaired Inflammatory and Innate Immune Response in COVID-19. Mol Cells. 2021 Jun 30; 44(6):384-391.
-
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist. J Clin Immunol. 2021 10; 41(7):1511-1514.
-
Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS. Nutrients. 2021 Jun 20; 13(6).
-
Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ TÂ cell help. Cell Rep. 2021 06 29; 35(13):109320.
-
Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries. J Med Virol. 2021 Oct; 93(10):5853-5863.
-
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms. Int J Mol Sci. 2021 Jun 09; 22(12).